000 | 01923 a2200529 4500 | ||
---|---|---|---|
005 | 20250517130042.0 | ||
264 | 0 | _c20180321 | |
008 | 201803s 0 0 eng d | ||
022 | _a1873-1708 | ||
024 | 7 |
_a10.1016/j.reprotox.2016.11.015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aToimela, T | |
245 | 0 | 0 |
_aIntra-laboratory validated human cell-based in vitro vasculogenesis/angiogenesis test with serum-free medium. _h[electronic resource] |
260 |
_bReproductive toxicology (Elmsford, N.Y.) _c06 2017 |
||
300 |
_a116-125 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Validation Study | ||
650 | 0 | 4 | _a2-Methoxyestradiol |
650 | 0 | 4 |
_aAdipose Tissue _xcytology |
650 | 0 | 4 |
_aAspirin _xpharmacology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCulture Media |
650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
650 | 0 | 4 |
_aErlotinib Hydrochloride _xpharmacology |
650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLaboratories |
650 | 0 | 4 |
_aLevamisole _xpharmacology |
650 | 0 | 4 |
_aMannitol _xpharmacology |
650 | 0 | 4 |
_aMethimazole _xpharmacology |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSerum |
650 | 0 | 4 |
_aStromal Cells _xdrug effects |
650 | 0 | 4 |
_aTeratogens _xtoxicity |
650 | 0 | 4 |
_aToxicity Tests _xmethods |
650 | 0 | 4 |
_aUmbilical Cord _xcytology |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
700 | 1 | _aHuttala, O | |
700 | 1 | _aSabell, E | |
700 | 1 | _aMannerström, M | |
700 | 1 | _aSarkanen, J R | |
700 | 1 | _aYlikomi, T | |
700 | 1 | _aHeinonen, T | |
773 | 0 |
_tReproductive toxicology (Elmsford, N.Y.) _gvol. 70 _gp. 116-125 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.reprotox.2016.11.015 _zAvailable from publisher's website |
999 |
_c26664324 _d26664324 |